Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Investigate the Relative Bioavailability of 2 Tablet Formulations and the Effect of Food on the Pharmacokinetics of BGB-58067 in Healthy Participants
Sponsor: BeOne Medicines
Summary
This study is being done to understand how the body processes 2 different tablet formulations of the study drug (BGB-58067) and how food intake influences the processing of the study drug by the body.
Official title: A Phase 1, Single Dose, Open-label, Randomized 4-Period, 4-Sequence Crossover Study to Assess the Relative Bioavailability of Two Tablet Formulations of BGB-58067 and the Effect of Food on the Pharmacokinetics of a Single Oral Dose of BGB-58067 Administered Simultaneously to Healthy Adult Participants
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2026-07-21
Completion Date
2028-07-01
Last Updated
2026-08-10
Healthy Volunteers
Yes
Conditions
Interventions
BGB-58067 Tablet (F-01 Formulation)
Administered orally
BGB-58067 Tablet (F-02 Formulation)
Administered orally
Locations (1)
Cmax Clinical Research
Adelaide, South Australia, Australia